Loading clinical trials...
Loading clinical trials...
Phase II Study of Nivolumab and Ipilimumab for Treatment of Metastatic/Recurrent Adenoid Cystic Carcinoma of All Anatomic Sites of Origin and Non-adenoid Cystic Carcinoma Malignant Tumors of the Salivary Gland
Conditions
Interventions
Ipilimumab
Laboratory Biomarker Analysis
+1 more
Locations
1
United States
Northwestern University
Chicago, Illinois, United States
Start Date
May 19, 2017
Primary Completion Date
February 24, 2021
Completion Date
August 11, 2025
Last Updated
January 18, 2024
NCT04895735
NCT05669664
NCT01175980
NCT01254617
NCT00859937
NCT00458978
Lead Sponsor
Northwestern University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions